The Patent Finder

Injectable Formulations for Treatment of Inflammatory Bowel Disease

Paragon Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2024/031569, filed May 30, 2024. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,304,956Dosing Regimen for Treating Inflammatory Bowel Disease
In force
 · High confidence
UsedRemaining
Paragon Therapeutics, Inc.In forceHigh confidence
US 12,404,334Methods of Treating Gastrointestinal Inflammatory Disease
In force
 · High confidence
Paragon Therapeutics, Inc.In forceHigh confidence
US 12,703,749Method of Treating Inflammatory Bowel Disease
In force
 · High confidence
Paragon Therapeutics, Inc.In forceHigh confidence
US 12,760,108Injectable Formulations for Treatment of Inflammatory Bowel Disease
In force
 · Medium confidence
Paragon Therapeutics, Inc.In forceMedium confidence
Application 19/302,809Long Acting ALPHA4BETA7 Targeting Molecule Compositions for the Treatment Gastrointestinal Inflammatory Disease
Pending
Not granted
Paragon Therapeutics, Inc.PendingNot granted
Application 19/393,395Long Acting ALPHA4BETA7 Targeting Molecule Compositions for the Treatment Gastrointestinal Inflammatory Disease
Pending
Not granted
Paragon Therapeutics, Inc.PendingNot granted
Application 19/705,182Method of Treating Gastrointestinal Inflammatory Disease
Pending
Not granted
Paragon Therapeutics, Inc.PendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Paragon Therapeutics, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited